Coagulation monitoring devices: Past, present, and future at the point of care

TrAC - Trends in Analytical Chemistry

Volumn 50, Issue , 2013, Pages 85-95

  Harris, Leanne F ^a   Castro López, Vanessa ^b   Killard, Anthony J ^a,c  

^a DUBLIN CITY UNIVERSITY   (Ireland)

^b CIC MICROGUNE   (Spain)

^c UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

Author keywords

Anticoagulant; Blood; Clinical diagnostics; Clotting time; Coagulation; Device; Hematology; Miniaturization; Monitoring; Point of care (POC)

Indexed keywords

BLOOD; DRUG PRODUCTS; MONITORING;

ANTICOAGULANT; CLINICAL DIAGNOSTICS; CLOTTING TIME; DEVICE; HEMATOLOGY; MINIATURIZATION; POINT OF CARE;

COAGULATION;

APTAMER; FIBRINOGEN; HEPARIN; QUANTUM DOT; THROMBIN; THROMBOPLASTIN; WARFARIN;

ACTIVATED CLOTTING TIME; AMPEROMETRIC BIOSENSOR; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; COAGULATION MONITORING DEVICE; COAGULOMETER; CYTOMETRY; DRUG MONITORING; FLUORESCENCE ANALYSIS; HUMAN; IMMUNOASSAY; IMPEDANCE; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; MEDICAL DEVICE; MEDICAL TECHNOLOGY; MICROFLUIDICS; PARTIAL THROMBOPLASTIN TIME; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN TIME; QUARTZ CRYSTAL MICROBALANCE; RESONANT TRANSDUCER; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TRANSDUCER;

EID: 84882263834     PISSN: 01659936     EISSN: 18793142     Source Type: Journal    
DOI: 10.1016/j.trac.2013.05.009     Document Type: Review

References (76)

1. Qari M.H. Combi. High throughput coagulation analyzers review. Chem. High Throughput Screen. 2005, 8:353-360.
2. Lippi G., Favalaro E.J., Franchini M., Guidi G.C. Milestones and perspectives in coagulation and haemostasis. Semin. Thromb. Haemost. 2009, 35:9-22.
3. Quick A.J., Stanleybrown M., Bancroft F.W. A study of the coagulation defect in hemophilia and in jaundice. Am. J. Med. Sci. 1935, 190:501-511.
4. Bates S.M., Weitz J.I. Coagulation assays. Circulation 2005, 112:53-60.
5. Perry D.J., Fitzmaurice D.A., Kitchen S., Mackie I.J., Mallett S. Point-of-care testing in haemostasis. Br. J. Haematol. 2010, 150:501-514.
6. Kitchen S., Makris M. Laboratory tests of hemostasis. Practical Hemostasis and Thrombosis 2005, 8-17. Blackwell Publishing, Massachusetts. D. O'Shaughnessy, M. Makris, D. Lillicrap (Eds.).
7. Heins M., Reinauer H. Automation in coagulation testing. J. Int. Fed. Clin. Chem. 1996, 8:117-122.
8. Rodak B.F., Fritsma G.A., Doig K. Hematology: Clinical Principles and Applications 2007, Elsevier Saunders, Missouri. third ed.
9. Kitchen S., McCraw A., Echenagucia M. Diagnosis of Hemophilia and other Bleeding Disorders: A laboratory manual 2010, World Federation of Hemophilia, Montréal.
10. Rosen S. Chromogenic methods in coagulation diagnostics. Hamostaseologie 2005, 25:259-266.
11. Ullman E.F., Kirakossian H., Singh S., Wu Z.P., Irvin B.R., Pease J.S., Switchenko A.C., Irvine J.D., Dafforn A., Skold C.N., Wagner D.B. Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence. Proc. Natl. Acad. Sci. USA 1994, 91:5426-5430.
12. Ullman E.F., Kirakossian H., Switchenko A.C., Ishkanian J., Ericson M., Wartchow C.A., Pirio M., Pease J., Irvin B.R., Singh S., Singh R., Patel R., Dafforn A., Davalian D., Skold C., Kurn N., Wagner D.B. Luminescent oxygen channeling immunoassay (LOCI): sensitive, broadly applicable homogeneous immunoassay. Clin. Chem. 1996, 42:1518-1526.
13. Kappel A., Ehm M. Immunoassays for diagnosis of coagulation disorders. Hamostaseologie 2010, 30:194-201.
14. Dempfle C.E., Borggrefe M. Point of care coagulation tests in critically ill patients. Semin. Thromb. Hemost. 2008, 34:445-450.
15. Weber C.F., Zacharowski K. Perioperative point of care coagulation testing. Dtsch. Arztebl. Int. 2012, 109:369-375.
16. Lee-Lewandrowski E., Gregory K., Lewandrowski K. Point of care testing in a large urban academic medical center: evolving test menu and clincal applications. Clin. Chim. Acta 2010, 411:1799-1805.
17. Storrow A.B., Lyon J.A., Porter M.W., Chuan Z., Jin Ho H., Lindsell C.J. A systematic review of emergency department point-of-care cardiac markers and efficiency measures. Point of Care 2009, 8:121-125.
18. Nichols J.H., Christenson R.H., Clarke W., Gronowski A., Hammett-Stabler C.A., Jacobs E., Kazmierczak S., Lewandrowski K., Price C., Sacks D.B., Sautter R.L., Shipp G., Sokoll L., Watson I.D., Winter W., Zucker M.L. Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing. Clin. Chim. Acta 2007, 379:14-28.
19. Goodnough L.T., Hill C.C. Use of point-of-care testing for plasma therapy. Transfusion 2012, 52:56-64.
20. Despotis G.J., Santoro S.A., Spitznagel E., Kater K.M., Cox J.L., Barnes P., Lappas D.G. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J. Thorac. Cardiovasc. Surg. 1994, 107:271-279.
21. Spiess B.D., Gillies B.S., Chandler W., Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J. Cardiothorac. Vasc. Anesth. 1995, 9:168-173.
22. Asimos A.W., Gibbs M.A., Marx J.A., Jacobs D.G., Erwin R.J., Norton H.J., Thomason M. Value of point-of-care blood testing in emergent trauma management. J. Trauma 2000, 48:1101-1108.
23. R. Lorincz, R. Hall, Solid state apparatus employing Hall effect sensors for detecting the coagulation of blood, Patent No. 6,136,271 (2000).
24. Welsby I.J., McDonnell E., El-Moalem H., Stafford-Smith M., Toffaletti J.G. Activated clotting time systems vary in precision and bias and are not interchangeable when following heparin management protocols during cardiopulmonary bypass. J. Clin. Monit. Comput. 2002, 17:287-292.
25. Prisco D., Paniccia R. Point-of-care testing of hemostasis in cardiac surgery. Thromb. J. 2003, 6:1-10.
26. Baglin T., Barrowcliffe T.W., Cohen A., Greaves M. Guidelines on the use and monitoring of heparin. Br. J. Haematol. 2006, 133:19-34.
27. M. Bartholow, Top 200 prescription drugs of 2009, <>, (last accessed 22.04.13). http://www.pharmacytimes.com/publications/issue/2010/May2010/RxFocusTopD rugs-0510.
28. Middeldorp S. Heparin: from animal organ extract to designer drug. Thromb. Res. 2008, 122:753-762.
29. Vacas M., Lafuente P.J., Unanue I., Iriarte J.A. Comparative study of two portable systems for oral anticoagulant monitoring. Haematol. J. 2004, 5:35-38.
30. Kitchen S., Preston F.E. A comparison of activated partial thromboplastin time methods for control of heparin therapy. Thromb. Haemost. 1993, 69:1106-1107.
31. Review Memorandum, Substantial equivalence determination decision summary, <>, (last accessed 22.04.13). http://www.accessdata.fda.gov/cdrh_docs/reviews/K093243.pdf.
32. CoaguSense Inc., CoaguSense self-testing PT monitoring system, Department of Health, 2010, <> (last accessed 22.04.13). http://www.coagusense.com/professionals.php.
33. Abramson H.A. The electrophoresis of the blood platelets of the horse with reference to their origin and to thrombus formation. J. Exp. Med. 1928, 47:677-683.
34. Shih C.C., Shih C.M., Su Y.Y., Su L.H.J., Chang M.S., Lin S.J. Quantitative evaluation of thrombosis by electrochemical methodology. Thromb. Res. 2003, 111:103-109.
35. Brock T.K., Gentile N.L., Louie R.F., Tran N.K., Kitano T., Kost G.J. Assessing thrombin generation at the point of care. Clin. Chem. 2009, 55:398-399.
36. Thuerlemann C., Haeberli A., Alberio L. Monitoring thrombin generation by electrochemistry: development of an amperometric biosensor screening test for plasma and whole blood. Clin. Chem. 2009, 55:505-512.
37. Donaldson M., Sullivan J., Norbeck A. Comparison of International Normalized Ratios provided by two point-of-care devices and laboratory-based venipuncture in a pharmacist-managed anticoagulation clinic. Am. J. Health Syst. Pharm. 2010, 67:1616-1622.
38. Challen L.M., Nguyen T.G., Villalon A. Impact of i-stat point of care implementation in a pharmacist-managed anticoagulation clinic: a retrospective analysis. Hosp. Pharm. 2011, 46:105-109.
39. M. Teodorczyk, E.J. Kiser, L.P. Olson, D. McAllister, V. V Yuzhakov, K.W. Leong, Electrochemical test strip with an integrated micro-needle and associated methods, Patent No. 7,144,495 (2006).
40. J. Arvind, Coagulation or lysis assays by measuring impedance, Patent No. 6,673,622 (2004).
41. Campbell R.A., Overmyer K.A., Bagnell C.R., Wolberg A.S. Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface. Arterioscler. Thromb. Vasc. Biol. 2009, 28:2247-2254.
42. Olson E.S., Whitney M.A., Friedman B., Aguilera T.A., Crisp J.L., Baik F.M., Jiang T., Baird S.M., Tsimikas S., Tsien R.Y., Nguyen Q.T. In vivo fluorescence imaging of atherosclerotic plaques with activatable cell-penetrating peptides targeting thrombin activity. Integr. Biol. 2012, 4:595-605.
43. Borissoff J.I., Joosen I.A., Versteylen M.O., Spronk H.M., ten Cate H., Hofstra L. Accelerated in vivo thrombin formation independently predicts the presence and severity of CT angiographic coronary atherosclerosis. Cardiovasc. Imaging 2012, 5:1201-1210.
44. Dempfle C., Schraml M., Besenthal I., Hansen R., Gehrke J., Korte W., Risch M., Quehenberger P., Handler S., Minar E., Schulz I., Zerback R. Multicentre evaluation of a new point-of-care test for the quantitative determination of D-dimer. Clin. Chim. Acta 2001, 307:211-218.
45. Geersing G.J., Toll D.B., Janssen K.J.M., Oudega R., Blikman M.J.C., Wijland R., de Vooght K.M.K., Hoes A.W., Moons K.G.M. Diagnostic accuracy and user-friendliness of 5 point-of-care D-dimer tests for the exclusion of deep vein thrombosis. Clin. Chem. 2010, 56:1758-1766.
46. Evans K., Amenhotep Z., Dawson D., Waters H., Ardern J. Hematology. The Immunoassay Handbook 2013, 795-816. Elsevier Ltd., London. D. Wild (Ed.).
47. Wild D.G. The Immunoassay Handbook 2013, Elsevier Ltd., London. fourth ed.
48. D'Orazio P. Biosensors in clincal chemistry. Clin. Chim. Acta 2003, 334:41-69.
49. Ganter M.T., Hofer C.K. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth. Analg. 2008, 106:1366-1375.
50. A. Warner, Microvisk Ltd., Handheld blood coagulation device, Trustech NHS 2012, <>, (last accessed 22.04.13). http://www.trustech.org.uk/case-study/microvisk/.
51. J. Bouchaud, R. Nixon, MEMS sensor determines clots, MEMS Monthly Market Brief, iSuppli Corporation, 3 (2010) 13.
52. G. Graham-Rowe, A portable cheap blood-clotting test, Technology Review 2008, <>, (last accessed 22.04.13). http://www.technologyreview.com/news/411164/a-portable-cheap-blood-clott ing-test/.
53. Stief T.W., Fareed J. Point of care: diagnostics in hemostasis - the wrong direction?. Clin. Appl. Thromb. Haemost. 2003, 9:191-195.
54. Gibbs N.M. Point-of-care assessment of antiplatelet agents in the perioperative period: a review. Anaesth. Intensive Care 2009, 37:354-369.
55. CAP Today, Coagulation Analysers - Point of Care Self Monitoring 2011, <>, (last accessed 22.04.13). http://www.cap.org/apps/docs/cap_today/0511/0511_CAPTODAY_CoagAnalyzersP OC-selfMonitorGuide.pdf.
56. Michelson A.D. Platelet function testing in cardiovascular diseases. Circulation 2004, 110:489-493.
57. Calatzis A., Leitner M., Panzer S. Monitoring anticoagulation of primary haemostasis-estimation of platelet function in whole blood assays. Hamostaseologie 2009, 29:279-284.
58. Harrison P. Platelet function analysis. Blood Rev. 2005, 19:111-123.
59. Michelson A.D. Methods for the measurement of platelet function. Am. J. Cardiol. 2009, 103:20-26.
60. Seidel H., Rahman M.M., Scharf R.E. Monitoring of antiplatelet therapy. Hamostaseologie 2011, 31:41-51.
61. Ferreiro J.L., Sibbing D., Angiolillo D.J. Platelet function testing and risk of bleeding complications. Thromb. Haemost. 2010, 103:1128-1135.
62. S.C. De Ribes, P. Eguiguren, Microfluidic device and method for fluid clotting time determination, Patent No. 2,201,365 B1 (2006).
63. Dudek M.M., Lindahl T.L., Killard A.J. Development of a point of care lateral flow device for measuring human plasma fibrinogen. Anal. Chem. 2010, 82:2029-2035.
64. Sinn S., Müller L., Drechsel H., Wandel M., Northoff H., Ziemer G., Wendel H.P., Gehring F.K. Platelet aggregation monitoring with a newly developed quartz crystal microbalance system as an alternative to optical platelet aggregometry. Analyst 2010, 135:2930-2938.
65. Tennico Y.H., Hutanu D., Koesdjojo M.T., Bartel C.M., Remcho V.T. On-chip aptamer-based sandwich assay for thrombin detection employing magnetic beads and quantum dots. Anal. Chem. 2010, 82:5591-5597.
66. Tovar-Lopez F.J., Rosengarten G., Westein E., Khoshmanesh K., Jackson S.P., Mitchell A., Nesbitt W.S. A microfluidics device to monitor platelet aggregation dynamics in response to strain rate micro-gradients in flowing blood. Lab Chip 2010, 10:291-302.
67. Dudek M.M., Kent N.J., Gu P., Fan Z.H., Killard A.J. Development of a fluorescent method for detecting the onset of coagulation in human plasma on microstructured lateral flow platforms. Analyst 2011, 136:1816-1825.
68. Evander M., Ricco A.J., Morser J., Kovacs G.T.A., Leung L.L.K., Giovangrandi L. Microfluidic impedance cytometer for platelet analysis. Lab Chip 2013, 13:722-729.
69. Enriquez L.J., Shore-Lesserson L. Point-of-care coagulation testing and transfusion algorithms. Br. J. Anaesth. 2009, 103:14-22.
70. Harris L.F., Castro-López V., Hammadi N., O'Donnell J.S., Killard A.J. Development of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins. Talanta 2010, 81:1725-1730.
71. Castro-López V., Harris L.F., O'Donnell J.S., Killard A.J. Quantification of unfractionated heparin in human plasma and whole blood by means of novel fluorogenic anti-FXa assays. J. Pharm. Biomed. Anal. 2011, 56:992-997.
72. L.F. Harris, P. Rainey, V. Castro-Lopez, J.S. O'Donnell, A.J. Killard, A microfluidic anti-Factor Xa assay device for point of care monitoring of anticoagulant therapy, Analyst, in press, http://dx.doi.org/10.1039/C3AN00401E.
73. Aizawa H., Kurosawa S., Tozuka M., Park J.W., Kobayashi K., Tanaka H. Conventional detection method of fibrinogen and fibrin degradation products using latex piezoelectric immunoassay. Biosens. Bioelectron. 2003, 18:765-771.
74. Bissell M., Sanfilippo F. Empowering patients with point-of-care testing. Trends Biotechnol. 2002, 20:269-270.
75. Giljohann D., Mirkin C.A. Drivers of biodiagnostic development. Nature 2009, 461-464.
76. Zhu H., Suter J.D., White I.M., Fan X. Aptamer based microsphere biosensor for thrombin detection. Sensors 2006, 6:785-795.